3. GoodRx Holdings, Inc. (NASDAQ:GDRX)
Number of Hedge Fund Holdings: 20
Forward P/E Ratio as of January 24: 13.61
Earnings Growth This Year: 17.14%
Stock Price as of January 24: $4.93
GoodRx Holdings, Inc. (NASDAQ:GDRX) is a leading digital healthcare platform that empowers consumers to access discounts on medications by comparing prices across pharmacies. The company serves millions of users, including individuals without insurance and those looking to lower costs. The company’s platform offers a wide range of services, including prescription price transparency, co-pay assistance, and direct-to-consumer e-commerce solutions.
One of the key areas of focus for GoodRx Holdings, Inc. (NASDAQ:GDRX) is its Pharma Manufacturer Solutions (PMS) offering. This segment has been experiencing significant momentum and has helped pharmaceutical manufacturers reach patients and physicians through innovative programs such as point-of-sale cash discounts, co-pay cards, and patient assistance programs. As of Q3, the company has signed over 72 point-of-sale cash programs, more than doubling the number of deals from the beginning of 2024. These programs not only provide immediate savings to consumers but also benefit manufacturers by driving incremental prescriptions and revenue. GoodRx Holdings, Inc. (NASDAQ:GDRX) e-commerce capabilities, which allow brands to integrate their direct-to-consumer experiences into the platform, further enhance the value proposition for both manufacturers and consumers.
GoodRx Holdings, Inc. (NASDAQ:GDRX) is also expanding its Integrated Savings Program (ISP), which complements health insurance by providing consumers with the lowest possible prices on covered medications. The ISP has been performing well and is expected to launch additional offerings, such as off-formulary brand deals, in early 2025. These programs aim to reduce patient script abandonment and increase the number of filled prescriptions, which can improve the overall economics of retail pharmacies.
